Skip to main content
. 2021 Apr 26;22(9):4517. doi: 10.3390/ijms22094517

Table 3.

Hemodynamic variables Part 2.

Baseline Reperfusion
30 45 60
Heart Rate (bpm)
HG Con 311 ± 54 205 ± 42 * 220 ± 69 192 ± 16 *
Lev0.3 297 ± 30 245 ± 87 259 ± 45 216 ± 52
CsA 292 ± 23 215 ± 63 214 ± 67 229 ± 47
Lev0.3 + CsA 306 ± 29 297 ± 43 267 ± 20 265 ± 23
Left Ventricular Developed Pressure (mmHg)
HG Con 117 ± 19 20 ± 16 * 28 ± 16 * 28 ± 11 *
Lev0.3 106 ± 14 15 ± 13 * 20 ± 19 * 25 ± 16 *
CsA 123 ± 26 35 ± 8 * 37 ± 13 * 35 ± 10 *
Lev0.3 + CsA 112 ± 21 23 ± 18 * 24 ± 13 * 24 ± 12 *
Coronary flow (mL/min)
HG Con 15 ± 3 7 ± 3 * 6 ± 1 * 6 ± 2 *
Lev0.3 13 ± 2 6 ± 1 * 6 ± 1 * 5 ± 1 *
CsA 15 ± 2 5 ± 1 * 6 ± 1 * 6 ± 1 *
Lev0.3 + CsA 14 ± 2 7 ± 2 * 7 ± 2 * 6 ± 1 *

Data are mean ± SD. HG = Hyperglycemia; Con = Control; Lev = Levosimendan; CsA = Cyclosporine A (mPTP inhibitor); * p < 0.05 vs. Baseline.